Y. Bejot, E. Touze, G. Osseby, and M. Giroud, Epidemiologie descriptive, Accidents vasculaires cérébraux, 2009.

P. Rothwell, A. Coull, M. Giles, S. Howard, L. Silver et al., Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study), The Lancet, vol.363, issue.9425, pp.1925-1958, 1981.
DOI : 10.1016/S0140-6736(04)16405-2

Y. Bejot, O. Rouaud, and J. Durier, Decrease in the Stroke Case Fatality Rates in a French Population-Based Twenty-Year Study, Cerebrovascular Diseases, vol.24, issue.5, pp.439-483, 2007.
DOI : 10.1159/000108434

T. Monteith, A. Gardener, T. Rundek, M. Elkind, and R. Sacco, Migraine and risk of stroke in older adults, Neurology, vol.85, issue.8, pp.715-721, 2015.
DOI : 10.1212/WNL.0000000000001854

H. Yaggi, J. Concato, W. Kernan, J. Lichtman, L. Brass et al., Obstructive Sleep Apnea as a Risk Factor for Stroke and Death, New England Journal of Medicine, vol.353, issue.19, pp.2034-2075, 2005.
DOI : 10.1056/NEJMoa043104

A. Pan, Q. Sun, O. Okereke, K. Rexrode, and F. Hu, Depression and Risk of Stroke Morbidity and Mortality, JAMA, vol.306, issue.11, pp.1241-1249, 2011.
DOI : 10.1001/jama.2011.1282

J. Whisnant, Modeling of Risk Factors for Ischemic Stroke : The Willis Lecture, Stroke, vol.28, issue.9, pp.1840-1844, 1997.
DOI : 10.1161/01.STR.28.9.1840

S. Yusuf, S. Hawken, S. Ôunpuu, T. Dans, A. Avezum et al., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, The Lancet, vol.364, issue.9438, pp.937-52, 2004.
DOI : 10.1016/S0140-6736(04)17018-9

O. Donnell, M. Xavier, D. Liu, L. Zhang, H. Chin et al., on behalf of the INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, Lancet, pp.376-112, 2010.

H. Adams, . Jr, B. Bendixen, L. Kappelle, J. Biller et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, vol.24, issue.1, pp.35-41, 1993.
DOI : 10.1161/01.STR.24.1.35

U. Schulz and P. Rothwell, Differences in Vascular Risk Factors Between Etiological Subtypes of Ischemic Stroke: Importance of Population-Based Studies, Stroke, vol.34, issue.8, pp.2050-2059, 2003.
DOI : 10.1161/01.STR.0000079818.08343.8C

N. Beckett, R. Peters, A. Fletcher, J. Staessen, L. Liu et al., Treatment of Hypertension in Patients 80 Years of Age or Older, New England Journal of Medicine, vol.358, issue.18, pp.1887-98, 2008.
DOI : 10.1056/NEJMoa0801369

R. Collins, R. Peto, S. Macmahon, P. Hebert, N. Fiebach et al., Blood pressure, stroke, and coronary heart disease, The Lancet, vol.335, issue.8693, pp.827-865, 1990.
DOI : 10.1016/0140-6736(90)90944-Z

J. Staessen, J. Gasowski, J. Wang, L. Thijs, D. Hond et al., Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials, The Lancet, vol.355, issue.9207, pp.865-872, 2000.
DOI : 10.1016/S0140-6736(99)07330-4

M. Sirol, A. Bouzamondo, P. Sanchez, and D. Lechat, Does statin therapy reduce the risk of stroke? A meta-analysis, Ann Med Interne (Paris), vol.152, pp.188-93, 2001.

H. Autorité and D. Santé, Bon usage des agents antiplaquettaires, recommandations de bonne pratique (rapport) Paris : HAS ; Juin 2012 Disponible sur : http://www.hassante.fr/portail/upload/docs, pp.2012-2019, 2015.

A. Laupacis, G. Alberts, and J. Dalen, Antithrombotic Therapy in Atrial Fibrillation, Chest, vol.114, issue.5, pp.579-89, 1998.
DOI : 10.1378/chest.114.5_Supplement.579S

H. Autorité and D. Santé, Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire, synthèse des recommandations (rapport) Paris : HAS ; 2014. Disponible sur, p.6, 2015.

. Progress-collaborative and . Group, Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack, Lancet, vol.358, pp.1033-1074, 2001.

G. Hankey and C. Warlow, Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations*, The Lancet, vol.354, issue.9188, pp.1457-63, 1999.
DOI : 10.1016/S0140-6736(99)04407-4

C. Granger, J. Alexander, J. Mcmurray, R. Lopes, E. Hylek et al., Apixaban versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.11, pp.981-92, 2011.
DOI : 10.1056/NEJMoa1107039

S. Connolly, J. Eikelboom, C. Joyner, H. Diener, R. Hart et al., Apixaban in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.364, issue.9, pp.806-823, 2011.
DOI : 10.1056/NEJMoa1007432

M. Patel, K. Mahaffey, J. Garg, G. Pan, D. Singer et al., Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.10, pp.883-91, 2011.
DOI : 10.1056/NEJMoa1009638

URL : https://hal.archives-ouvertes.fr/hal-01038111

A. Trialists-'collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, vol.324, issue.7329, pp.71-86, 2002.
DOI : 10.1136/bmj.324.7329.71

H. Barnett, D. Taylor, M. Eliasziw, A. Fox, G. Ferguson et al., Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis, New England Journal of Medicine, vol.339, issue.20, pp.1415-1440, 1998.
DOI : 10.1056/NEJM199811123392002

J. Mas, G. Chatellier, B. Beyssen, A. Branchereau, T. Moulin et al., Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis, Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis, pp.1660-71, 2006.
DOI : 10.1056/NEJMoa061752

URL : https://hal.archives-ouvertes.fr/hal-00493696

F. Woimant, D. Broucker, T. Vassel, and P. , Groupe de travail « Organisation des structures de soins dans la pathologie neuro-vasculaire » de la Société Française Neuro- Vasculaire. Prise en charge des accidents vasculaires cérébraux en France métropolitaine, Rev Neurol (Paris), vol.159, pp.5-543, 2003.

A. Hyenne, G. Jeanblanc, G. Osseby, M. Giroud, and E. Combier, Caractérisation des différents types de prise en charge des accidents vasculaires cérébraux en France : des unités neuro-vasculaires aux services conventionnels. Résultats d'une enquête par questionnaire, Rev Neurol (Paris), vol.163, pp.12-1215, 2007.

S. Debiais, I. Bonnaud, B. Giraudeau, D. Perrotin, J. Gigot et al., Cr??ation d???une fili??re neuro-vasculaire r??gionale : ??valuation de la prise en charge ?? 18 mois, Revue Neurologique, vol.163, issue.8-9, pp.8-9, 2007.
DOI : 10.1016/S0035-3787(07)91464-2

M. Hommel and F. Woimant, La filière des accidents vasculaires cérébraux, Revue du praticien, vol.56, pp.1452-1454, 2006.

B. Indredavik, F. Bakke, S. Slørdahl, R. Rokseth, and L. Håheim, Stroke Unit Treatment : 10-Year Follow-Up, Stroke, vol.30, issue.8, pp.1524-1527, 1999.
DOI : 10.1161/01.STR.30.8.1524

A. Evans, I. Perez, F. Harraf, A. Melbourn, J. Steadman et al., Can differences in management processes explain different outcomes between stroke unit and stroke-team care?, The Lancet, vol.358, issue.9293, pp.1586-92, 2001.
DOI : 10.1016/S0140-6736(01)06652-1

. Société-française-neurovasculaire, Recommandations pour la création d'Unités neuro-vasculaires, Rev Neurol, vol.157, pp.1447-56, 2001.

H. Autorité and D. Santé, Place des unités neuro-vasculaires dans la prise en charge des patients atteints d'accident vasculaire cérébral (rapport ANAES) ANAES juillet, Disponible sur, p.6, 2002.

M. Giroud and Y. Béjot, Malgré une incidence stable, il faut se préparer à davantage d'AVC, Le Concours Médical, vol.131, issue.622, p.16, 2009.

Y. Béjot, M. Giroud, O. Rouaud, I. Benatru, T. Moreau et al., Évolution sur vingt ans des taux d'incidence et de mortalité des AVC au sein de la population de Dijon intra-muros : 1985-2004, pp.305-324, 2007.

K. Asplund, M. Sukhova, P. Wester, and B. Stegmayr, Diagnostic Procedures, Treatments, and Outcomes in Stroke Patients Admitted to Different Types of Hospitals, Stroke, vol.46, issue.3, pp.806-812, 2015.
DOI : 10.1161/STROKEAHA.114.007212

J. Wei, J. Wang, Y. Huang, M. Liu, Y. Wu et al., Secondary Prevention of Ischemic Stroke in Urban China, Stroke, vol.41, issue.5, pp.967-974, 2010.
DOI : 10.1161/STROKEAHA.109.571463

S. Ramsay, P. Whincup, S. Wannamethee, O. Papacosta, L. Lennon et al., Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study, Journal of Public Health, vol.29, issue.3, pp.251-257, 2007.
DOI : 10.1093/pubmed/fdm040

H. Tomita, J. Hagii, N. Metoki, S. Saito, G. Shiroto et al., Impact of sexe difference on severity and functional outcome in patients with cardioembolic stroke, J Stroke Cerebrovasc Dis, vol.2, pp.1052-3057, 2015.

C. Dehlendorff, K. Andersen, and T. Olsen, Sex Disparities in Stroke: Women Have More Severe Strokes but Better Survival Than Men, Journal of the American Heart Association, vol.4, issue.7, p.1967, 2015.
DOI : 10.1161/JAHA.115.001967

M. Reeves, C. Bushnell, G. Howard, W. Gaegano, J. Duncan et al., Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes, The Lancet Neurology, vol.7, issue.10, pp.915-926, 2008.
DOI : 10.1016/S1474-4422(08)70193-5

P. Sabouret, J. Dallongeville, P. Steg, P. Cacoub, M. Krempf et al., REACH : registre observationnel prospectif international chez des patients à risque d'événements athérothrombotiques, Résultats des données françaises sur le contrôle des facteurs de risque et les stratégies thérapeutiques à un an. Symposium HAS-BMJ, 2010.

P. Rothwell, A. Coull, M. Giles, S. Howard, L. Silver et al., Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study), The Lancet, vol.363, issue.9425, pp.1925-1958, 1981.
DOI : 10.1016/S0140-6736(04)16405-2

Y. Béjot, G. Osseby, V. Gremeaux, J. Durier, O. Rouaud et al., Changes in risk factors and preventive treatments by stroke subtypes over 20years: A population-based study, Journal of the Neurological Sciences, vol.287, issue.1-2, pp.84-88, 2009.
DOI : 10.1016/j.jns.2009.08.062

P. Bath, R. Iddensen, and F. Bath, Low-Molecular-Weight Heparins and Heparinoids in Acute Ischemic Stroke : A Meta-Analysis of Randomized Controlled Trials, Stroke, vol.31, issue.7, pp.1770-1778, 2000.
DOI : 10.1161/01.STR.31.7.1770

I. Stroke and C. Group, The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischemic stroke, Lancet, vol.349, pp.1569-1581, 1997.

P. Sandercock, C. Counsell, and M. Tseng, Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Review). The Cochrane collaboration. The Cochrane Library, 2011.

B. Indredavik, G. Rohweder, E. Naalsund, and S. Lydersen, Medical Complications in a Comprehensive Stroke Unit and an Early Supported Discharge Service, Stroke, vol.39, issue.2, pp.414-434, 2008.
DOI : 10.1161/STROKEAHA.107.489294

R. Devanport, M. Dennis, I. Wellwood, and C. Warlow, Complications After Acute Stroke, Stroke, vol.27, issue.3, pp.415-420, 1996.
DOI : 10.1161/01.STR.27.3.415

K. Johnston, J. Li, P. Lyden, S. Hanson, T. Feasby et al., Medical and Neurological Complications of Ischemic Stroke : Experience From the RANTTAS Trial, Stroke, vol.29, issue.2, pp.447-453, 1998.
DOI : 10.1161/01.STR.29.2.447

I. Maier, M. Bauerle, and P. Kermer, Risk prediction of very early recurrence, death and progression after acute ischaemic stroke, European Journal of Neurology, vol.60, issue.4, pp.599-604, 2013.
DOI : 10.1111/ene.12037

B. Coull, L. Williams, L. Goldstein, J. Meschia, D. Heitzman et al., Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association), Stroke, vol.33, issue.7, pp.1934-1976, 2002.
DOI : 10.1161/01.STR.0000028456.18614.93

S. Paolucci, C. Gandolfo, L. Provinciali, R. Torta, V. Toso et al., The Italian multicenter observational study on post???stroke depression (DESTRO), Journal of Neurology, vol.27, issue.5, pp.556-62, 2006.
DOI : 10.1007/s00415-006-0058-6

M. Rothberg, S. Herzig, P. Pekow, J. Avrunin, T. Lagu et al., Association Between Sedating Medications and Delirium in Older Inpatients, Journal of the American Geriatrics Society, vol.113, issue.86-9, pp.923-930, 2013.
DOI : 10.1111/jgs.12253

N. Bazin and L. Bratu, Depression in the elderly: prodroma or risk factor for dementia? A critical review of the literature, Geriatr Psychol Neuropsychiatr Vieil, vol.12, issue.3, pp.289-97, 2014.

M. Ganguli, Depression, cognitive impairment and dementia: Why should clinicians care about the web of causation?, Indian J Psychiatry, vol.51, pp.29-34, 2009.

H. Henon, F. Lebert, L. Durieu, O. Godefroy, C. Lucas et al., Confusional State in Stroke : Relation to Preexisting Dementia, Patient Characteristics, and Outcome, Stroke, vol.30, issue.4, pp.773-779, 1999.
DOI : 10.1161/01.STR.30.4.773

M. Gonzalez-castellon and R. Marshall, Statin Use and Brain Hemorrhage, JAMA Neurology, vol.71, issue.11, pp.1353-1354, 2014.
DOI : 10.1001/jamaneurol.2014.2463

P. Laloux, Risk and Benefit of Statins in Stroke Secondary Prevention, Current Vascular Pharmacology, vol.11, issue.6, pp.812-818, 2013.
DOI : 10.2174/157016111106140128113121

S. Bak, I. Tsiropoulos, J. Kjaersgaard, M. Andersen, E. Mellerup et al., Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study, Stroke, vol.33, issue.6, pp.1465-73, 2002.
DOI : 10.1161/01.STR.0000018589.56991.BA

D. Shin, Y. Oh, C. Eom, and S. Park, Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis, Journal of Neurology, vol.124, issue.4, pp.686-695, 2014.
DOI : 10.1007/s00415-014-7251-9

F. Chollet, J. Tardy, J. Albucher, C. Thalamas, E. Berard et al., Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial, The Lancet Neurology, vol.10, issue.2, pp.123-130, 2011.
DOI : 10.1016/S1474-4422(10)70314-8

H. Autorité and D. Santé, Accident vasculaire cérébral : prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, indications de la thrombolyse, recommandations de bonne pratique (rapport) Paris : HAS ; Mai, Disponible sur, p.6, 2009.

N. Venketasubramanian, J. Röther, D. Bhatt, B. Pasquet, J. Mas et al., Two-Year Vascular Event Rates in Patients with Symptomatic Cerebrovascular Disease: The REACH Registry, Cerebrovascular Diseases, vol.32, issue.3, pp.254-260, 2011.
DOI : 10.1159/000328650

D. Hackam and J. Spence, Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study, Stroke, vol.38, issue.6, pp.1881-1885, 2007.
DOI : 10.1161/STROKEAHA.106.475525

P. Rothwell, M. Giles, A. Chandratheva, L. Marquardt, O. Geraghty et al., Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison, The Lancet, vol.370, issue.9596, pp.1432-1474, 2007.
DOI : 10.1016/S0140-6736(07)61448-2

B. Abramson, V. Huckell, S. Anand, T. Forbes, A. Gupta et al., Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease-executive summary, Can J Cardiol, vol.21, pp.997-1006, 2005.

Y. Béjot, M. Zeller, L. Lorgis, O. Troisgros, C. Aboa-eboulé et al., Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.3, pp.348-353, 2013.
DOI : 10.1136/jnnp-2012-303267

A. Bell, Bulletin du congrès en cardiologie Réduction optimale du risque de maladie vasculaire diffuse : cibler la maladie artérielle périphérique, pp.75-78, 2008.

G. Steg, D. Bhatt, P. Wilson, D. Agostino, R. Ohman et al., One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis, JAMA, vol.297, issue.11, pp.1197-1206, 2007.
DOI : 10.1001/jama.297.11.1197

A. Kazadi, I. Sibon, M. Lafitte, Y. Pucheu, P. Renou et al., Int??r??t d???un programme court de prise en charge globale de l???ath??roscl??rose sur la r??duction du risque vasculaire ?? distance d???un infarctus c??r??bral, Revue Neurologique, vol.169, issue.4, pp.314-320, 2013.
DOI : 10.1016/j.neurol.2012.09.017

E. Glader, M. Sjölander, M. Eriksson, and M. Lundberg, Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke, Stroke, vol.41, issue.2, pp.397-401, 2010.
DOI : 10.1161/STROKEAHA.109.566950

D. Schryver, E. Gijn, J. Kappelle, J. Koudstaal, and P. , Non???adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke, Journal of Neurology, vol.26, issue.11, pp.1316-1321, 2005.
DOI : 10.1007/s00415-005-0858-0

C. Bushnell, D. Olson, X. Zhao, W. Pan, L. Zimmer et al., Secondary preventive medication persistence and adherence 1 year after stroke, Neurology, vol.77, issue.12, pp.1182-1190, 2011.
DOI : 10.1212/WNL.0b013e31822f0423

D. Kumbhani, G. Steg, C. Cannon, K. Eagle, S. Smith et al., Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis, The American Journal of Medicine, vol.126, issue.8, pp.693-700, 2013.
DOI : 10.1016/j.amjmed.2013.01.033

F. Raffe, A. Jacquin, O. Milleret, J. Durier, D. Sauze et al., Evaluation of the Possible Impact of a Care Network for Stroke and Transient Ischemic Attack on Rates of Recurrence, European Neurology, vol.65, issue.4, pp.239-283, 2011.
DOI : 10.1159/000326298

M. Quellec, M. Symphorien, S. Debruxelles, S. Sagnier, M. Poli et al., Peut-on am??liorer le suivi des patients en post-AVC??? L???exp??rience de l???UNV de Bordeaux dans la coordination des soins par une IDE, Revue Neurologique, vol.171, issue.S1, p.215, 2015.
DOI : 10.1016/j.neurol.2015.01.097

H. Adams, . Jr, B. Bendixen, L. Kappelle, J. Biller et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, vol.24, issue.1, pp.35-41, 1993.
DOI : 10.1161/01.STR.24.1.35

D. La-haute-autorité-de-santé, Synthèse du guide parcours de soin fibrillation atriale Paris : HAS ; Mars 2014, Disponible sur

D. Conroy, R. Pyorala, K. Sans, S. Menotti, A. et al., Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, European Heart Journal, vol.24, issue.11, pp.987-1003, 2003.
DOI : 10.1016/S0195-668X(03)00114-3